Green Cross Holdings Corporation (KRX:005250)
South Korea
· Delayed Price · Currency is KRW 13,670
-60 (-0.44%)
At close: Mar 24, 2025, 3:30 PM KST
Green Cross Holdings Revenue
In the year 2024, Green Cross Holdings had annual revenue of 2.20T KRW with 7.14% growth. Green Cross Holdings had revenue of 565.10B in the quarter ending December 31, 2024, with 4.34% growth.
Revenue
2,204.86B
Revenue Growth
+7.14%
P/S Ratio
0.28
Revenue / Employee
14.60B
Employees
151
Market Cap
610.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,204.86B | 146.92B | 7.14% |
| Dec 31, 2023 | 2,057.94B | -21.62B | -1.04% |
| Dec 31, 2022 | 2,079.56B | 239.00B | 12.99% |
| Dec 31, 2021 | 1,840.56B | 121.23B | 7.05% |
| Dec 31, 2020 | 1,719.33B | 225.74B | 15.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |